Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
MRMD
$0.06
-2.63%
MRMD
· Marimed Inc.
Market Cap
$22.57M
Shares
403.04M
Volume · Oct 20
131.65K
Avg daily vol (3M)
561.09K
All webcasts
Earnings call · FY2022 Q3
Marimed Inc. (MRMD) Q3 2022 Earnings Call
Revenue
$33.91M
+2.1% YoY
Diluted EPS
$0.01
+0% YoY
Gross margin
47.7%
-7.0 pp YoY
Net income
$2.71M
+34% YoY
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Nov 7, 2022.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Revenue
Lowered
full year 2022
|
$132M – $135M | — | $134.01M within | |
|
Gross margin
full year 2022
|
48% – 49% | — | — | |
|
Non-GAAP Adjusted EBITDA
Lowered
full year 2022
|
$32M – $35M | Non-GAAP | — | |
|
Capital expenditures
Lowered
full year 2022
|
$16M – $17M | — | — |
SEC filing · Item 2.02
8-K earnings release
Filed Nov 7, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 8, 2022 · complete as-filed document